StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Silo Pharma's total debt was $1.06K at Mar 31, 2021. For fiscal 2020 it was $4.25K, down 71.7% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$4.25K-71.7%
FY2012Dec 31, 2012$15.00K–
FY2011Dec 31, 2011$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021$1.06K–
Q4 FY2020Dec 31, 2020$4.25K–
Q4 FY2012Dec 31, 2012$15.00K–
Q3 FY2012Sep 30, 2012$15.00K–

More Silo Pharma figures

See a number that looks wrong?